Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
18 05 2021
Historique:
entrez: 19 5 2021
pubmed: 20 5 2021
medline: 16 11 2021
Statut: epublish

Résumé

Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by

Identifiants

pubmed: 34006659
pii: mBio.00855-21
doi: 10.1128/mBio.00855-21
pmc: PMC8262942
pii:
doi:

Substances chimiques

Antigens, Bacterial 0
Bacterial Proteins 0
Meningococcal Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 Marjuki et al.

Références

J Infect Dis. 2017 Nov 27;216(9):1130-1140
pubmed: 28968661
J Infect Dis. 2003 May 15;187(10):1616-28
pubmed: 12721942
Microbiology (Reading). 2002 Jun;148(Pt 6):1813-1819
pubmed: 12055301
J Clin Microbiol. 2019 Feb 27;57(3):
pubmed: 30567750
Sci Rep. 2015 Aug 18;5:12888
pubmed: 26283022
Emerg Infect Dis. 2004 Apr;10(4):674-8
pubmed: 15200858
MMWR Morb Mortal Wkly Rep. 2017 May 19;66(19):509-513
pubmed: 28520709
Vaccine. 2012 May 30;30 Suppl 2:B87-97
pubmed: 22607904
Expert Rev Vaccines. 2009 Jul;8(7):851-61
pubmed: 19538112
Vaccine. 2010 Aug 23;28(37):6086-93
pubmed: 20619376
mSphere. 2020 Apr 8;5(2):
pubmed: 32269159
Vaccine. 2013 Feb 4;31(7):1113-6
pubmed: 23261039
MMWR Recomm Rep. 2013 Mar 22;62(RR-2):1-28
pubmed: 23515099
PLoS One. 2014 Sep 23;9(9):e107240
pubmed: 25247300
Lancet Infect Dis. 2012 Aug;12(8):597-607
pubmed: 22569484
Hum Vaccin Immunother. 2017 Feb;13(2):255-265
pubmed: 27960595
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Vaccine. 2012 Sep 21;30(43):6163-74
pubmed: 22871351
Vaccine. 2018 Jan 2;36(1):29-35
pubmed: 29183735
Pediatr Infect Dis J. 2013 Apr;32(4):364-71
pubmed: 23114369
Infect Immun. 1998 Apr;66(4):1334-41
pubmed: 9529050
Mol Biol Evol. 2006 Feb;23(2):254-67
pubmed: 16221896
Clin Infect Dis. 2017 Apr 15;64(8):1115-1122
pubmed: 28158417
mSphere. 2017 Nov 15;2(6):
pubmed: 29152576
Infect Immun. 2002 Feb;70(2):702-7
pubmed: 11796602
J Infect. 2019 Nov;79(5):426-434
pubmed: 31505201
Vaccine. 2013 Sep 13;31(40):4416-20
pubmed: 23856330
Clin Vaccine Immunol. 2014 Jul;21(7):966-71
pubmed: 24807056
J Clin Pathol. 2004 Oct;57(10):1015-21
pubmed: 15452151
Emerg Infect Dis. 2019 Mar;25(3):434-440
pubmed: 30789140
Postgrad Med. 2016 Aug;128(6):548-56
pubmed: 27467048
FEMS Microbiol Rev. 2007 Jan;31(1):89-96
pubmed: 17168996
Popul Health Metr. 2013 Sep 10;11(1):17
pubmed: 24016339
PLoS One. 2013 May 24;8(5):e65043
pubmed: 23717687
Hum Vaccin Immunother. 2015;11(1):5-13
pubmed: 25483509
Hum Vaccin Immunother. 2018 May 4;14(5):1118-1130
pubmed: 29565712
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Trends Microbiol. 2006 Mar;14(3):120-4
pubmed: 16469496
Lancet Infect Dis. 2010 Dec;10(12):853-61
pubmed: 21075057
Curr Protoc Bioinformatics. 2002 Aug;Chapter 2:Unit 2.3
pubmed: 18792934
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
BMJ. 2003 Feb 15;326(7385):365-6
pubmed: 12586669
Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2714-9
pubmed: 26888286
N Engl J Med. 2020 Jan 23;382(4):318-327
pubmed: 31971677
J Clin Microbiol. 2004 Jan;42(1):320-8
pubmed: 14715772
Vaccine. 2013 Mar 15;31(12):1569-75
pubmed: 23352429
PLoS One. 2011 May 05;6(5):e19361
pubmed: 21573213

Auteurs

Henju Marjuki (H)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

How-Yi Chang (HY)

IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Nadav Topaz (N)

CDC Foundation Field Employee assigned to the Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Melissa J Whaley (MJ)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Jeni Vuong (J)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Alexander Chen (A)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Laurel T Jenkins (LT)

IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Fang Hu (F)

IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Susanna Schmink (S)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Adam C Retchless (AC)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Jennifer D Thomas (JD)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Anna M Acosta (AM)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Lucy A McNamara (LA)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Heidi M Soeters (HM)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sarah Mbaeyi (S)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Xin Wang (X)

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA gqe8@cdc.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH